ConductScience.org, home

Paper32550995

Construction and Evaluation of Molecular Models: Guide and Design of Novel SE Inhibitors.

An Y and 6 others. ACS Med Chem Lett, 2020. Cited by 8 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Construction and Evaluation of Molecular Models: Guide and Design of Novel SE Inhibitors. Papers, record 32550995. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32550995

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Construction and Evaluation of Molecular Models: Guide and Design of Novel SE Inhibitors.
PubMed
Journal
ACS Med Chem Lett
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.56
iCite
Revised in PubMed
2024-03-29
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1An YYunfei
2Dong YYue
3Min LLiu
4Zhao LLiyu
5Zhao DDongmei
6Han JJun
7Sun BBin

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19379925VERIFY3D: assessment of protein models with three-dimensional profiles.Methods Enzymol1997https://conductscience.org/library/papers/9379925PubMed
226310892Design, synthesis, and structure-activity relationship studies of novel thienopyrrolidone derivatives with strong antifungal activity against Aspergillus fumigates.Eur J Med Chem2015https://conductscience.org/library/papers/26310892PubMed
31509259Structure-based strategies for drug design and discovery.Science1992https://conductscience.org/library/papers/1509259PubMed
421175238Echinocandin antifungal drugs in fungal infections: a comparison.Drugs2011https://conductscience.org/library/papers/21175238PubMed
527494168Design, synthesis, and structure-activity relationship studies of benzothiazole derivatives as antifungal agents.Eur J Med Chem2016https://conductscience.org/library/papers/27494168PubMed
627816138Nosocomial Fungal Infections: Epidemiology, Infection Control, and Prevention.Infect Dis Clin North Am2016https://conductscience.org/library/papers/27816138PubMed
727955926Discovery of biphenyl imidazole derivatives as potent antifungal agents: Design, synthesis, and structure-activity relationship studies.Bioorg Med Chem2017https://conductscience.org/library/papers/27955926PubMed
822902032The biology and chemistry of antifungal agents: a review.Bioorg Med Chem2012https://conductscience.org/library/papers/22902032PubMed
931044071In vitro polymyxin activity against clinical multidrug-resistant fungi.Antimicrob Resist Infect Control2019https://conductscience.org/library/papers/31044071PubMed
1030765301Design, synthesis and biological evaluation of amide-pyridine derivatives as novel dual-target (SE, CYP51) antifungal inhibitors.Bioorg Med Chem2019https://conductscience.org/library/papers/30765301PubMed
1116772406Invasive fungal infections: a review of epidemiology and management options.J Med Microbiol2006https://conductscience.org/library/papers/16772406PubMed
1230626872Structure and inhibition mechanism of the catalytic domain of human squalene epoxidase.Nat Commun2019https://conductscience.org/library/papers/30626872PubMed
1328802152Comparison and analysis of the structures and binding modes of antifungal SE and CYP51 inhibitors.J Mol Graph Model2017https://conductscience.org/library/papers/28802152PubMed
1435531010Construction of antifungal dual-target (SE, CYP51) pharmacophore models and the discovery of novel antifungal inhibitors.RSC Adv2019https://conductscience.org/library/papers/35531010PubMed
15251018014-Aminopyridyl-based CYP51 inhibitors as anti-Trypanosoma cruzi drug leads with improved pharmacokinetic profile and in vivo potency.J Med Chem2014https://conductscience.org/library/papers/25101801PubMed
1627301676Synthesis and investigation of novel benzimidazole derivatives as antifungal agents.Bioorg Med Chem2016https://conductscience.org/library/papers/27301676PubMed
1731279297Synthesis of new thiazolyl-pyrazolyl-1,2,3-triazole derivatives as potential antimicrobial agents.Eur J Med Chem2019https://conductscience.org/library/papers/31279297PubMed
1824836547Diagnosis of deep cutaneous fungal infections: correlation between skin tissue culture and histopathology.J Am Acad Dermatol2014https://conductscience.org/library/papers/24836547PubMed
1921229992Detailed mechanism of squalene epoxidase inhibition by terbinafine.J Chem Inf Model2011https://conductscience.org/library/papers/21229992PubMed
2014696385Modeller: generation and refinement of homology-based protein structure models.Methods Enzymol2003https://conductscience.org/library/papers/14696385PubMed

See all 25 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn Papers
37358753Curcumin interferes with chitin synthesis in Aedes aegypti: a computational and experimental investigation.Mol Divers2024https://conductscience.org/library/papers/37358753

Source PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
SELENBP18991PubTator's text mininghttps://conductscience.org/library/genes/8991NCBI Gene
SQLE6713PubTator's text mininghttps://conductscience.org/library/genes/6713NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32550995

GET https://conductscience.org/api/papers/v1/32550995/references?page=2